Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.

Standard

Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia. / Jeldres, Claudio; Isbarn, Hendrik; Capitanio, Umberto; Zini, Laurent; Bhojani, Naeem; Shariat, Shahrokh F; Cloutier, Vincent; Lattouf, Jean-Baptiste; Duclos, Alain; Jolivet-Tremblay, Martine; Valiquette, Luc; Saad, Fred; Graefen, Markus; Montorsi, Francesco; Perrotte, Paul; Karakiewicz, Pierre I.

in: J UROLOGY, Jahrgang 182, Nr. 2, 2, 2009, S. 626-632.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Jeldres, C, Isbarn, H, Capitanio, U, Zini, L, Bhojani, N, Shariat, SF, Cloutier, V, Lattouf, J-B, Duclos, A, Jolivet-Tremblay, M, Valiquette, L, Saad, F, Graefen, M, Montorsi, F, Perrotte, P & Karakiewicz, PI 2009, 'Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.', J UROLOGY, Jg. 182, Nr. 2, 2, S. 626-632. <http://www.ncbi.nlm.nih.gov/pubmed/19535100?dopt=Citation>

APA

Jeldres, C., Isbarn, H., Capitanio, U., Zini, L., Bhojani, N., Shariat, S. F., Cloutier, V., Lattouf, J-B., Duclos, A., Jolivet-Tremblay, M., Valiquette, L., Saad, F., Graefen, M., Montorsi, F., Perrotte, P., & Karakiewicz, P. I. (2009). Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia. J UROLOGY, 182(2), 626-632. [2]. http://www.ncbi.nlm.nih.gov/pubmed/19535100?dopt=Citation

Vancouver

Bibtex

@article{9565e8c59ad1482e9923603f40083e17,
title = "Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.",
abstract = "PURPOSE: Benign prostatic hyperplasia affects 60% of men at the age of 60 years. Transurethral resection of the prostate is the gold standard of therapy. We assessed the 30-day mortality rate after transurethral resection of the prostate for benign prostatic hyperplasia, identified risk factors related to 30-day mortality and developed a model that discriminates among individual 30-day mortality risk levels. MATERIALS AND METHODS: We performed development (7,362) and external validation (7,362) of a multivariable logistic regression model predicting the individual probability of 30-day mortality after transurethral resection of the prostate based on an administrative data set (Quebec Health Plan) of 14,724 patients 43 to 99 years old treated between January 1, 1989 and December 31, 2000. RESULTS: Overall 30-day mortality occurred in 58 patients (0.4%) undergoing transurethral resection of the prostate. On univariable analyses increasing age (p",
author = "Claudio Jeldres and Hendrik Isbarn and Umberto Capitanio and Laurent Zini and Naeem Bhojani and Shariat, {Shahrokh F} and Vincent Cloutier and Jean-Baptiste Lattouf and Alain Duclos and Martine Jolivet-Tremblay and Luc Valiquette and Fred Saad and Markus Graefen and Francesco Montorsi and Paul Perrotte and Karakiewicz, {Pierre I}",
year = "2009",
language = "Deutsch",
volume = "182",
pages = "626--632",
journal = "J UROLOGY",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

RIS

TY - JOUR

T1 - Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.

AU - Jeldres, Claudio

AU - Isbarn, Hendrik

AU - Capitanio, Umberto

AU - Zini, Laurent

AU - Bhojani, Naeem

AU - Shariat, Shahrokh F

AU - Cloutier, Vincent

AU - Lattouf, Jean-Baptiste

AU - Duclos, Alain

AU - Jolivet-Tremblay, Martine

AU - Valiquette, Luc

AU - Saad, Fred

AU - Graefen, Markus

AU - Montorsi, Francesco

AU - Perrotte, Paul

AU - Karakiewicz, Pierre I

PY - 2009

Y1 - 2009

N2 - PURPOSE: Benign prostatic hyperplasia affects 60% of men at the age of 60 years. Transurethral resection of the prostate is the gold standard of therapy. We assessed the 30-day mortality rate after transurethral resection of the prostate for benign prostatic hyperplasia, identified risk factors related to 30-day mortality and developed a model that discriminates among individual 30-day mortality risk levels. MATERIALS AND METHODS: We performed development (7,362) and external validation (7,362) of a multivariable logistic regression model predicting the individual probability of 30-day mortality after transurethral resection of the prostate based on an administrative data set (Quebec Health Plan) of 14,724 patients 43 to 99 years old treated between January 1, 1989 and December 31, 2000. RESULTS: Overall 30-day mortality occurred in 58 patients (0.4%) undergoing transurethral resection of the prostate. On univariable analyses increasing age (p

AB - PURPOSE: Benign prostatic hyperplasia affects 60% of men at the age of 60 years. Transurethral resection of the prostate is the gold standard of therapy. We assessed the 30-day mortality rate after transurethral resection of the prostate for benign prostatic hyperplasia, identified risk factors related to 30-day mortality and developed a model that discriminates among individual 30-day mortality risk levels. MATERIALS AND METHODS: We performed development (7,362) and external validation (7,362) of a multivariable logistic regression model predicting the individual probability of 30-day mortality after transurethral resection of the prostate based on an administrative data set (Quebec Health Plan) of 14,724 patients 43 to 99 years old treated between January 1, 1989 and December 31, 2000. RESULTS: Overall 30-day mortality occurred in 58 patients (0.4%) undergoing transurethral resection of the prostate. On univariable analyses increasing age (p

M3 - SCORING: Zeitschriftenaufsatz

VL - 182

SP - 626

EP - 632

JO - J UROLOGY

JF - J UROLOGY

SN - 0022-5347

IS - 2

M1 - 2

ER -